What type of study is this?

This is a Cohort Study study (also classified as: Quantitative Study).

December 8, 2025Blood

CD39 defines an exhausted effector memory T cell subset associated with poor outcome in Acute Myeloid Leukemia: Immunophenotypic and transcriptomic analysis

View Full Paper

Ask AI

Bookmark

Higher frequencies of CD39+ T cells linked to lower complete response rates in AML patients.
Gene set enrichment analysis shows upregulation of exhaustion pathways in CD39+ T cells.
Multiparametric flow cytometry reveals CD39+ cells enriched in both Treg and non-Treg CD4+ T cells.
Findings suggest CD39 is a functional biomarker for immune dysfunction and chemoresistance in AML.

No takes yet. Share an insight, caveat, or question.

Analysis reveals CD39+ T cells correlate with treatment response and poor survival in acute myeloid leukemia.

Joon Seong Park (2025) studied this question.

View Full Paper

Ask AI

Bookmark